Plasma Levels of Vascular Endothelial Growth Factor After Treatment for Cerebral Arteriovenous Malformations | Zendy

Grace H. Kim | Zendy; David Hahn | Zendy; Christopher P. Kellner | Zendy; Zachary L. Hickman | Zendy; Ricardo J. Komotar | Zendy; Robert M. Starke | Zendy; William J. Mack | Zendy; J Mocco | Zendy; Robert A. Solomon | Zendy; E. Sander Connolly | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Plasma Levels of Vascular Endothelial Growth Factor After Treatment for Cerebral Arteriovenous Malformations

Author(s) -

Grace H. Kim,

David Hahn,

Christopher P. Kellner,

Zachary L. Hickman,

Ricardo J. Komotar,

Robert M. Starke,

William J. Mack,

J Mocco,

Robert A. Solomon,

E. Sander Connolly

Publication year - 2008

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.107.512442

Subject(s) - medicine , vascular endothelial growth factor , pathophysiology , arteriovenous malformation , angiogenesis , vegf receptors , gastroenterology , endocrinology , urology , pathology , surgery

The role of abnormal angiogenesis in the formation and progression of cerebral arteriovenous malformations (AVMs) is unclear. Previous studies have demonstrated increased local expression of vascular endothelial growth factor (VEGF) in AVM tissue and increased circulating levels of VEGF in AVM patients. We sought to further investigate the role of VEGF in AVM pathophysiology by examining changes in plasma VEGF levels in patients undergoing treatment for AVMs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research